Imagyn Eyes Australia
- Share via
Dow Jones
NEWPORT BEACH — Imagyn Medical Technologies Inc. said it has received clearance to begin marketing its SiteSelect breast biopsy system in Australia. The company said it will start shipping the product in January and plans to launch the product in the U.S. early next year.
SiteSelect allows sampling of a breast mass without open surgery.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
